Shortcut to Body
  1. HOME
  2. All KODEX ETFs
  3. Product Details

Asset type Leveraged/Inverse

Kodex Leverage(122630)

Double performance!! Realize double performance on a daily basis following KOSPI 200 movements.

Last data obtained Quotes delayed at least 20 minutes. Market data provided by KOSCOM.

  • Current Price (KRW)

    18,880

    up 680 (3.74%)

  • iNAV (KRW)

    19,086

    up 692 (3.76%)

  • Trading Volume (shares)

    25,587,064

About Product

* as of Apr 23, 2024

Benchmark Index

KOSPI200 363.60 (up7.62)

The KOSPI 200 Index consists of 200 KOSPI-listed stocks selected based on various factors including, but not limited to, market representativeness, industry representativeness, and liquidity.

View index information in detail

Key Facts

Basic Information - Net Assets, Benchmark Index, Gross Expense Ratio, Dividend, Benchmark Index, Base Currency, General Administrator, Trustee
Net Assets 2,141 (billion) Base Currency KRW
Inception Date February 22, 2010 General
Administrator
Shinhan Aitas
Gross Expense
Ratio
0.64%
(AP : 0.001%, Manager Fee :0.599%, Trustee Fee :0.02%, General Administrator Fee :0.02%)
Trustee HSBC Seoul Branch
Dividend No dividend distribution Related
Documents
-
  • Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing.
  • Collective investment schemes are not insured by the Korea Deposit Insurance Corporation.
  • The performance quoted represents past performance and does not guarantee future results.
  • Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold.
  • Current performance may be lower or higher than the performance quoted.
  • This information is not warranted to be accurate, complete, or timely.
  • Neither KOSCOM nor Samsung Asset Management is responsible for any damages or losses arising from any use of the information on this website.
  • This website is made in the Korean language, and if there shall arise any conflict between the Korean version and any translation thereof,
    including this -English translation, the Korean version shall prevail.